The development of decision limits for the GH-2000 detection methodology using additional insulin-like growth factor-I and amino-terminal pro-peptide of type III collagen assays-Reference-Cited by-同舟云学术

The development of decision limits for the GH-2000 detection methodology using additional insulin-like growth factor-I and amino-terminal pro-peptide of type III collagen assays

Published:2015-01-21 Issue:9 Volume:7 Page:745-755
ISSN:1942-7603
Container-title:Drug Testing and Analysis
language:en
Short-container-title:Drug Test. Analysis

Author:

Holt Richard I. G.¹,Böhning Walailuck¹,Guha Nishan²,Bartlett Christiaan³,Cowan David A.³,Giraud Sylvain⁴,Bassett E. Eryl⁵,Sönksen Peter H.¹,Böhning Dankmar⁶

Affiliation:

1. Human Development and Health Academic Unit, Faculty of Medicine; University of Southampton; UK

2. Nuffield Division of Clinical Laboratory Sciences; University of Oxford; UK

3. Department of Pharmacy and Forensic Science, Drug Control Centre; King's College London; UK

4. Swiss Laboratory for Doping Analyses; University Center of Legal Medicine, Geneva and Lausanne; Switzerland

5. School of Mathematics, Statistics and Actuarial Science; University of Kent; UK

6. Southampton Statistical Sciences Research Institute; University of Southampton; UK

Funder

World Anti-Doping Agency

International Association of Athletics Federations

Partnership for Clean Competition

Publisher

Wiley

Subject

Spectroscopy,Pharmaceutical Science,Environmental Chemistry,Analytical Chemistry

Reference18 articles.

1. Detecting growth hormone abuse in athletes;Holt;Anal. Bioanal. Chem.,2011

2. Detection of growth hormone abuse in sport;Powrie;Growth Horm. IGF Res.,2007

3. The development of decision limits for the implementation of the GH-2000 detection methodology using current commercial insulin-like growth factor-I and amino-terminal pro-peptide of type III collagen assays;Erotokritou-Mulligan;Growth Horm. IGF Res.,2012

4. Interlaboratory agreement of insulin-like growth factor 1 concentrations measured by mass spectrometry;Cox;Clin. Chem.,2014

5. Court of Arbitration for Sport CAS 2011/A/2566 Andrus Veerpalu v http://www.tas-cas.org/fileadmin/user_upload/256620FINAL20Award20_internet_.pdf

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combined statistical decision limits based on two GH-2000 scores for the detection of growth hormone misuse;Statistical Methods in Medical Research;2022-05-25

2. Growth hormone isoform testing in capillary dried blood spots: Results from single and multiple dose administration studies and large‐scale field collections;Drug Testing and Analysis;2022-03-10

3. Procollagen type III amino‐terminal propeptide and insulin‐like growth factor I as biomarkers of growth hormone administration;Drug Testing and Analysis;2021-09-06

4. Coupling Complete Blood Count and Steroidomics to Track Low Doses Administration of Recombinant Growth Hormone: An Anti-Doping Perspective;Frontiers in Molecular Biosciences;2021-06-10

5. Comparison of normal distribution–based and nonparametric decision limits on the GH‐2000 score for detecting growth hormone misuse (doping) in sport;Biometrical Journal;2020-11-09